Launch Decision Domain
Formulation & Scale-Up
Commercially relevant formulation, format, stability and scale-up considerations for dietary supplement and medical-nutrition programmes.
4
guides
Formulation & Scale-Up
Navigating Lifecycle Impairment Mechanisms for Dietary Supplements and Functional Foods: From Formulation to Systemic Exposure
Buyers face significant risk from diverse formulation, processing, and physiological mechanisms that measurably impair the identity, potency, release, bioaccessibility, systemic exposure, or safety of dietary supplements and functional foods. This can lead to reduced efficacy and commercial failure if not addressed across the product lifecycle.
Formulation & Scale-Up
Optimizing Multi-Strain Probiotic Formulations: Addressing Viability, Delivery, and Efficacy Challenges
The formulation challenge is preventing significant strain-level viability loss and compromised clinical efficacy in multi-strain probiotics. Buyers must address degradation from moisture, manufacturing, and GI transit.
Formulation & Scale-Up
Optimizing Lipophilic Active Softgels: Managing Oxidation, Stability, and Bioavailability Through Formulation and Packaging
Ensuring the long-term chemical and physical stability, dissolution performance, and oral bioavailability of lipophilic actives in softgels is challenged by complex interactions between fill composition, shell material, packaging, and supply-chain conditions.
Launch Strategy
Supplement Manufacturing Timeline: The Critical Path from Product Brief to First Commercial Batch
The primary buyer risk involves committing to launch timelines, claims, or formulations without first defining critical product, market, and regulatory parameters, leading to costly rework or missed opportunities.
No guides match the selected topic on this page. Try another tag or clear the filter.
A Complex Decision Deserves a Defined Scope
Need a Product Decision Built Around Your Specific Programme?
These guides help you frame the right questions. Product-specific formulation, market, evidence and technical decisions belong in a defined Paid Discovery or bespoke FSMP scope.
EXPLORE RELATED INTELLIGENCE